20.45
price up icon6.29%   1.21
pre-market  Pre-mercato:  19.77   -0.68   -3.33%
loading
Precedente Chiudi:
$19.24
Aprire:
$19.5
Volume 24 ore:
549.14K
Relative Volume:
0.92
Capitalizzazione di mercato:
$1.43B
Reddito:
$133.62M
Utile/perdita netta:
$-177.37M
Rapporto P/E:
-7.0761
EPS:
-2.89
Flusso di cassa netto:
$23.50M
1 W Prestazione:
+7.01%
1M Prestazione:
-15.25%
6M Prestazione:
+6.84%
1 anno Prestazione:
+4.12%
Intervallo 1D:
Value
$19.21
$20.50
Intervallo di 1 settimana:
Value
$19.06
$20.50
Portata 52W:
Value
$15.31
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Nome
Xencor Inc
Name
Telefono
626-305-5900
Name
Indirizzo
465 N. HALSTEAD ST., PASADENA, CA
Name
Dipendente
280
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
XNCR's Discussions on Twitter

Confronta XNCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XNCR
Xencor Inc
20.45 1.43B 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-12 Iniziato Wells Fargo Overweight
2024-12-02 Aggiornamento Piper Sandler Neutral → Overweight
2024-04-16 Reiterato BTIG Research Buy
2024-02-28 Downgrade Piper Sandler Overweight → Neutral
2023-05-19 Iniziato BofA Securities Buy
2022-12-06 Iniziato Cowen Outperform
2022-10-13 Aggiornamento Raymond James Outperform → Strong Buy
2022-09-21 Iniziato JP Morgan Overweight
2022-07-06 Ripresa Canaccord Genuity Buy
2022-02-11 Iniziato BMO Capital Markets Outperform
2022-01-21 Iniziato SMBC Nikko Outperform
2021-12-15 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-02-24 Aggiornamento Raymond James Mkt Perform → Outperform
2020-03-04 Iniziato Barclays Underweight
2020-02-25 Aggiornamento Guggenheim Neutral → Buy
2020-01-30 Iniziato RBC Capital Mkts Outperform
2019-11-20 Ripresa Guggenheim Neutral
2019-08-07 Downgrade Guggenheim Buy → Neutral
2019-08-07 Downgrade Raymond James Outperform → Mkt Perform
2019-06-13 Iniziato Mizuho Buy
2019-04-12 Iniziato Guggenheim Buy
2019-03-27 Iniziato Berenberg Buy
2019-03-15 Iniziato Raymond James Outperform
2018-09-10 Ripresa BTIG Research Buy
2018-03-28 Ripresa Leerink Partners Outperform
2017-03-02 Iniziato Instinet Neutral
2017-03-02 Reiterato Wedbush Outperform
2016-10-04 Iniziato Piper Jaffray Overweight
2015-12-22 Iniziato Canaccord Genuity Buy
2015-08-05 Reiterato MLV & Co Buy
2015-02-12 Reiterato Oppenheimer Outperform
2015-01-28 Reiterato MLV & Co Buy
2014-07-11 Iniziato Oppenheimer Outperform
Mostra tutto

Xencor Inc Borsa (XNCR) Ultime notizie

pulisher
Jan 21, 2025

Down -21.69% in 4 Weeks, Here's Why Xencor (XNCR) Looks Ripe for a Turnaround - Yahoo Finance

Jan 21, 2025
pulisher
Jan 21, 2025

JPMorgan Chase & Co. Acquires 3,635 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

After Plunging -20.27% in 4 Weeks, Here's Why the Trend Might Reverse for Xencor (XNCR) - Yahoo Finance

Jan 20, 2025
pulisher
Jan 18, 2025

Xencor (NASDAQ:XNCR) Stock Price Down 3.8%What's Next? - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Xencor Becomes Oversold (XNCR) - Nasdaq

Jan 17, 2025
pulisher
Jan 16, 2025

Xencor (XNCR) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jan 16, 2025
pulisher
Jan 15, 2025

Here's Why Xencor (XNCR) is Poised for a Turnaround After Losing -23.68% in 4 Weeks - Yahoo Finance

Jan 15, 2025
pulisher
Jan 10, 2025

Xencor (NASDAQ:XNCR) Trading Down 9.3%Here's Why - MarketBeat

Jan 10, 2025
pulisher
Jan 09, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat

Jan 09, 2025
pulisher
Jan 09, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

How To Trade (XNCR) - Stock Traders Daily

Jan 08, 2025
pulisher
Jan 02, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Principal Financial Group Inc. - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

Is Xencor (NASDAQ:XNCR) Using Too Much Debt? - Simply Wall St

Dec 31, 2024
pulisher
Dec 28, 2024

(XNCR) Investment Analysis - Stock Traders Daily

Dec 28, 2024
pulisher
Dec 27, 2024

Geode Capital Management LLC Raises Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 27, 2024
pulisher
Dec 26, 2024

26,831 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Sanctuary Advisors LLC - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Sanctuary Advisors LLC Takes $540,000 Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 26, 2024
pulisher
Dec 24, 2024

Barclays PLC Raises Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 24, 2024
pulisher
Dec 24, 2024

Barclays PLC Increases Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 24, 2024
pulisher
Dec 20, 2024

Intrahepatic Cholangiocarcinoma Pipeline Insights 2024: Therapies, Clinical Trials, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapeutics - The Globe and Mail

Dec 20, 2024
pulisher
Dec 20, 2024

Fmr LLC Buys 12,729 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Stake Increased by Jane Street Group LLC - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

State Street Corp Reduces Stake in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 19, 2024
pulisher
Dec 18, 2024

When (XNCR) Moves Investors should Listen - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 15, 2024

Xencor (NASDAQ:XNCR) Earns Overweight Rating from Analysts at Wells Fargo & Company - Defense World

Dec 15, 2024
pulisher
Dec 15, 2024

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Dec 15, 2024
pulisher
Dec 14, 2024

Xencor's SWOT analysis: biotech stock balances promise and challenges - Investing.com

Dec 14, 2024
pulisher
Dec 14, 2024

Xencor's SWOT analysis: biotech stock balances promise and challenges By Investing.com - Investing.com Canada

Dec 14, 2024
pulisher
Dec 13, 2024

Wells Fargo Initiates Coverage of Xencor (XNCR) with Overweight Recommendation - MSN

Dec 13, 2024
pulisher
Dec 12, 2024

All You Need to Know About Xencor (XNCR) Rating Upgrade to Buy - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

Xencor (NASDAQ:XNCR) Now Covered by Wells Fargo & Company - MarketBeat

Dec 12, 2024
pulisher
Dec 12, 2024

Rockefeller Capital Management L.P. Invests $205,000 in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 12, 2024
pulisher
Dec 09, 2024

The Manufacturers Life Insurance Company Reduces Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Dec 09, 2024
pulisher
Dec 09, 2024

Charles Schwab Investment Management Inc. Has $12.61 Million Holdings in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 09, 2024
pulisher
Dec 07, 2024

(XNCR) Technical Pivots with Risk Controls - Stock Traders Daily

Dec 07, 2024
pulisher
Dec 07, 2024

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

46,700 Shares in Xencor, Inc. (NASDAQ:XNCR) Purchased by Polar Asset Management Partners Inc. - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Readystate Asset Management LP Buys New Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Wall Street Analysts Think Xencor (XNCR) Could Surge 31.58%: Read This Before Placing a Bet - MSN

Dec 05, 2024
pulisher
Dec 05, 2024

RTW Investments LP Takes $11.56 Million Position in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

RA Capital Management L.P. Makes New Investment in Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 05, 2024
pulisher
Dec 05, 2024

Point72 Asset Management L.P. Purchases 1,858,440 Shares of Xencor, Inc. (NASDAQ:XNCR) - MarketBeat

Dec 05, 2024
pulisher
Dec 04, 2024

Xencor director Montgomery sells $397,930 in stock - Investing.com India

Dec 04, 2024
pulisher
Dec 04, 2024

Xencor director Montgomery sells $397,930 in stock By Investing.com - Investing.com Canada

Dec 04, 2024
pulisher
Dec 04, 2024

Fed. Circ. Judge Condemns 'Nonsense' Law In Antibody Fight - Law360

Dec 04, 2024
pulisher
Dec 03, 2024

Piper Sandler Upgrades Xencor (XNCR) - MSN

Dec 03, 2024
pulisher
Dec 03, 2024

Xencor, Inc.'s (NASDAQ:XNCR) 26% Share Price Surge Not Quite Adding Up - Simply Wall St

Dec 03, 2024
pulisher
Dec 03, 2024

Xencor stock hits 52-week high at $26.89 amid robust gains - Investing.com Canada

Dec 03, 2024

Xencor Inc Azioni (XNCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):